These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2380672)
1. Effects of acylcarnitine transferase blockade on metabolism and function in the normally and underperfused canine myocardium. Seitelberger R; Huber S; Schwarzacher S; Raberger G J Clin Chem Clin Biochem; 1990 May; 28(5):341-6. PubMed ID: 2380672 [TBL] [Abstract][Full Text] [Related]
2. Effects of the acylcarnitine-transferase blocking agent sodium 2[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) on metabolism and regional function in the underperfused canine myocardium. Seitelberger R; Kraupp O; Winkler M; Brugger G; Raberger G J Cardiovasc Pharmacol; 1985; 7(2):273-80. PubMed ID: 2581080 [TBL] [Abstract][Full Text] [Related]
3. Effects of acylcarnitine-transferase blocking agent sodium 2[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA) on cardiodynamics and myocardial metabolism in dogs. Seitelberger R; Kraupp O; Beck A; Bacher S; Raberger G J Cardiovasc Pharmacol; 1984; 6(5):902-8. PubMed ID: 6209498 [TBL] [Abstract][Full Text] [Related]
4. Influence of carnitine acyltransferase inhibitors on the performance and metabolism of rat cardiac muscle. Reinauer H; Adrian M; Rösen P; Schmitz FJ J Clin Chem Clin Biochem; 1990 May; 28(5):335-9. PubMed ID: 2380671 [TBL] [Abstract][Full Text] [Related]
5. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine. Lopaschuk GD; Wall SR; Olley PM; Davies NJ Circ Res; 1988 Dec; 63(6):1036-43. PubMed ID: 3197271 [TBL] [Abstract][Full Text] [Related]
6. Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats. Rösen P; Reinauer H Acta Physiol Hung; 1988; 71(2):271-80. PubMed ID: 3389170 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium. Gross GJ; Pieper GM; Warltier DC J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S76-84. PubMed ID: 2447429 [TBL] [Abstract][Full Text] [Related]
8. Acute effects of the coronary vasodilator carbocromen on myocardial oxygen consumption, substrate uptake and mechanical performance in intact dogs. Vik-Mo H; Mjøs OD; Smiseth O; Riemersma RA; Oliver MF Arzneimittelforschung; 1981; 31(7):1088-91. PubMed ID: 7196756 [TBL] [Abstract][Full Text] [Related]
9. Effects of POCA on metabolism and function in the ischemic rat heart. Paulson DJ; Noonan JJ; Ward KM; Stanley H; Sherratt A; Shug AL Basic Res Cardiol; 1986; 81(2):180-7. PubMed ID: 3741356 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated, perfused hearts of streptozotocin-diabetic rats. Rösen P; Reinauer H Metabolism; 1984 Feb; 33(2):177-85. PubMed ID: 6694560 [TBL] [Abstract][Full Text] [Related]
11. Nicotinic acid, free fatty acids and myocardial function during coronary occlusion and reperfusion in the dog. Lamping KA; Menahan LA; Gross GJ J Pharmacol Exp Ther; 1984 Dec; 231(3):532-8. PubMed ID: 6502512 [TBL] [Abstract][Full Text] [Related]
12. Effects of acylcarnitine-transferase inhibitors on adenine nucleotide metabolism and ischemic tissue injury in isolated perfused rat heart. Shikama H; Noshiro O; Ohta A; Ohata I Jpn Heart J; 1988 Sep; 29(5):723-34. PubMed ID: 3221447 [TBL] [Abstract][Full Text] [Related]
13. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs. Abe Y; Kitada Y; Narimatsu A J Pharmacol Exp Ther; 1993 May; 265(2):819-25. PubMed ID: 8496827 [TBL] [Abstract][Full Text] [Related]
14. Effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate on fatty acid and glucose metabolism in perfused rat hearts determined using iodine-125 16-iodohexadecanoate. Sherratt HS; Gatley SJ; DeGrado TR; Ng CK; Holden JE Biochem Biophys Res Commun; 1983 Dec; 117(3):653-7. PubMed ID: 6667268 [TBL] [Abstract][Full Text] [Related]
15. [Isoflurane: coronary blood flow and myocardial metabolism in patients with coronary heart disease]. Larsen R; Hilfiker O; Philbin DM; Sonntag H Anaesthesist; 1986 May; 35(5):284-90. PubMed ID: 3488695 [TBL] [Abstract][Full Text] [Related]
16. The effect of beta-adrenoceptor blocking drugs on free fatty acid and glucose utilization of the isolated canine heart with normal and restricted flow in the presence and absence of noradrenaline. Szekeres L; Csik V; Udvary E Acta Biol Med Ger; 1978; 37(5-6):817-20. PubMed ID: 33514 [TBL] [Abstract][Full Text] [Related]